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a b s t r a c t
The multi-domain non-structural protein 3 of SARS-coronavirus is a component of the viral replication/
transcription complex (RTC). Among other domains, it contains three sequentially arranged macro-
domains: the X domain and subdomains SUD-N as well as SUD-M within the “SARS-unique domain”.
The X domain was proposed to be an ADP-ribose-1”-phosphatase or a poly(ADP-ribose)-binding protein,
whereas SUD-NM binds oligo(G)-nucleotides capable of forming G-quadruplexes. Here, we describe the
application of a reverse genetic approach to assess the importance of these macrodomains for the
activity of the SARS-CoV RTC. To this end, Renilla luciferase-encoding SARS-CoV replicons with
selectively deleted macrodomains were constructed and their ability to modulate the RTC activity was
examined. While the SUD-N and the X domains were found to be dispensable, the SUD-M domain was
crucial for viral genome replication/transcription. Moreover, alanine replacement of charged amino-acid
residues of the SUD-M domain, which are likely involved in G-quadruplex-binding, caused abrogation of
RTC activity.
& 2015 Elsevier Inc. All rights reserved.
Introduction
The Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)
belongs to lineage b of the genus Betacoronavirus. During the SARS
outbreak of 2003 (see Hilgenfeld and Peiris (2013), for a recent
review), the genome of SARS-CoV was sequenced within three
weeks of the discovery of the virus (Marra et al., 2003; Rota et al.,
2003) and subjected to detailed annotation shortly thereafter
(Snijder et al., 2003). At the same time and in subsequent years,
leads for antiviral therapy were described (Anand et al., 2003; Yang
et al., 2005; see Hilgenfeld (2014), for a recent review). However,
the detailed molecular characterization of viral genome replication
and the assembly of viral particles was initially restricted to
specialized high-safety laboratories. This limitation was overcome
by the ﬁnding that SARS-CoV replicons are able to replicate
autonomously in transfected host cells (Almazán et al., 2006; Ge
et al., 2007; Eriksson et al., 2008; Pan et al., 2008; Wang et al., 2008;
reviewed in Almazán et al., 2014). Replicons, in particular those
encoding a reporter gene, considerably facilitate the functional
analysis of molecular determinants that control the replication
and transcription of the SARS-CoV genome. SARS-CoV replicons
consist of the genomic 50 and 30 untranslated regions and an open
reading frame (ORF) encoding the two polyproteins (pp1a and, via a
(-1) frame-shift, pp1ab) that are processed into 16 non-structural
proteins (Nsp1 to Nsp16) to form the replication/transcription
complex (RTC, Fig. 1A). Among the Nsps, Nsp3 is a multi-domain
polypeptide comprising the following structurally organized
domains (Serrano et al., 2009; Johnson et al., 2010): the ubiquitin-
like domain 1 (UB1), the partially disordered acidic domain (Ac), the
X domain, and the SARS-unique domain (SUD). This is followed by
the second ubiquitin-like domain (UB2), which is usually consid-
ered part of the next domain, the papain-like protease (PLpro). C-
terminal to these, there is the nucleic-acid-binding domain (NAB),
followed by a longer stretch of amino-acid residues apparently
lacking secondary structure (occasionally called “coronavirus group
2 marker (G2M)”; Neuman et al., 2014) and the ﬁrst transmem-
brane region (TM1). The zinc-ﬁnger (ZF) is the only domain on the
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luminal side of the membrane; the second transmembrane region
(TM2) and, ﬁnally, the uncharacterized Y domain are localized near
the C-terminus of Nsp3 (Fig. 1B, see Neuman et al. (2014)).
The X domain was shown to have a macrodomain fold and
proposed to be an ADP-ribose-1″-phosphate phosphatase (ADRP) or
a poly(ADP-ribose)-binding module (Saikatendu et al., 2005; Egloff
et al., 2006). We have shown previously that the SUD contains two
consecutive macrodomains, called SUD-N and SUD-M (Tan et al.,
2009). Although their functional role in the viral replication cycle
remains unknown, we have shown that these macrodomains bind
nucleic acids that contain long guanine stretches capable of forming
G-quadruplexes (Tan et al., 2007, 2009).
In the present study, we investigated the X, SUD-N, and SUD-M
macrodomains to determine whether they play important roles in
viral genome replication/transcription and whether they act in cis
or in trans. To this end, we have introduced in-frame deletions into
the X and SUD regions of the SARS-CoV replicon, into which a
reporter gene (Renilla luciferase, RLuc) was introduced under the
control of the transcription regulatory sequence (TRS) for SARS-
CoV structural protein M (Fig. 1A). In addition, the functional role
of the SUD C-terminal region (SUD-C, a frataxin-like domain with
as yet unknown function (Johnson et al., 2010)), was assessed in a
similar way. The reporter gene-containing replicons were tested
for their ability to support the activity of the RTC in the synthesis
of subgenomic replicon RNA and to assess whether the deleted
functions could be rescued in trans. The data presented indicate a
crucial role for the SUD-Mmacrodomain for viral RTC activity, thus
lending support to the signiﬁcance of the previously observed
binding of SUD to oligo(G)-containing nucleic acids (Tan et al.,
2007, 2009). This observation was additionally reinforced by the
analysis of replicons in which amino-acid mutations have been
introduced in subdomains presumably involved in the interaction
with G-quadruplexes (Tan et al., 2009).
Results
Introduction of deletions and point mutations into the SARS-CoV
replicon encoding Renilla luciferase
Comparing genome transcription with genome replication, it
was previously shown that the replicon pBAC-REP, which was
lacking a reporter gene, was able to replicate in mammalian cells
(Almazán et al., 2006). These data encouraged us to introduce a
luciferase reporter gene into the replicon pBAC-REP to enable the
quantitative detection of viral genome replication simply by
measuring the luciferase activity. The Renilla luciferase was chosen
as a reporter protein because of its longer half-life as compared to
that of the ﬁreﬂy luciferase (see Materials and methods and Tanaka
et al., 2012). However, the constructed full-length SARS-CoV
replicon DNA, pBAC-REP-RLuc, was too large (approximately
33 kb) to ensure the correctness of desired deletions and/or
mutations. Therefore, the engineered mutants lacking different
genome fragments (complete SUD, or subdomains SUD-N, SUD-M,
SUD-NM, and, ﬁnally, SUD-C, Fig. 1C) were ﬁrst introduced by site-
directed mutagenesis into the shorter plasmid pBAC-SfoI-MluI
(approx. 15 kb, Supplementary Fig. 1B, Almazán et al., 2006). The
fragments containing the deletions were then excised from these
pBAC-SfoI-MluI-derived plasmids and transferred back into plas-
mid pBAC-REP-RLuc. To recover the replication/transcription activ-
ity, the correctly oriented MluI-MluI fragment was inserted into
the ﬁnal plasmids. Supplementary Fig. 1 depicts our main strategy
exempliﬁed by the construction of the SUD-deleted SARS-CoV
replicon encoding Renilla luciferase as reporter protein (pBAC-
ΔSUD-REP-RLuc).
To examine whether SUD function within the RTC might be
connected to its binding to oligo(G)-stretches capable of forming
G-quadruplexes (Tan et al., 2009), a SARS-CoV replicon containing
the mutations K565A, K568A, and E571A within the SUD-M
domain (referred to as the mut4 set of mutations) was constructed
following a similar approach. We had shown previously that these
mutations abrogate G-quadruplex binding to SUD-M (Tan et al.
2009). The replicon containing the mutations K476A and K477A
(the mut2 set of mutations) located near the C-terminus of the
SUD-N domain was also prepared for comparison, since these
mutations had a weaker effect on SUD-oligo(G) binding according
to zone-interference gel electrophoresis (Tan et al., 2009). To
further test our hypothesis, the mutation sets mut2 and mut4
were also introduced into the replication-competent replicon
pBAC-ΔX-REP-RLuc lacking the X domain (see below and Fig. 4A
and B).
Replication-competence of the reporter gene-containing SARS-CoV
replicon pBAC-REP-RLuc
To ensure that the reporter gene expression directly correlated
with viral genome synthesis, the level of viral RNA synthesis was
measured in parallel to Renilla luciferase activity. This was
achieved by quantitative RT-PCR (qRT-PCR) using primers covering
the non-structural protein 1 (Nsp1) region (see Materials and
methods). There was a direct correlation of Renilla luciferase
expression with the amount of viral RNA synthesis in mammalian
cells transfected with the SARS-CoV replicon pBAC-REP-RLuc
(Fig. 2A and B, columns “REP”). Due to the speciﬁcity of the
forward and reverse primers, the qRT-PCR system gave a non-
signiﬁcant background (Fig. 2B, column “mock”). A replication-
defective construct, pBAC-REP(NR)-RLuc, with a reverse
Fig. 1. Schematic presentations (not to scale) of the genetically engineered SARS-
CoV replicon encoding Renilla luciferase (A), of the domain organization of Nsp3
(B), and of constructs with deleted fragments (ΔX, SUD-ΔN, SUD-ΔM, SUD-ΔNM,
and SUD-ΔC) within domains X–SUD of Nsp3 (C). Nsp – nonstructural protein 1–16,
Mpro – main (or 3C-like, 3CL) protease, prim/pol – non-canonical polymerase
activity (Xiao et al., 2012; te Velthuis et al., 2012), ssRBP – single-stranded RNA-
binding protein, RdRp – RNA-dependent RNA polymerase, Hel – superfamily-1
helicase, ExoN/(7)N-GMtase – 30-to-50 exonuclease/7N-guanylmethyltransferase,
NendoU – U-speciﬁc endoribonuclease, 20O-Mtase – 20O-methyltransferase, TRS-
M – transcription-regulatory sequence of the M protein, RLuc – Renilla luciferase, N
– nucleocapsid protein, pA – a synthetic poly(A) tail, Rz – hepatitis delta virus
ribozyme, BGH – bovine growth hormone termination and polyadenylation
sequence, UB1 – ubiquitin-like domain 1, Ac – acidic domain, X – X domain, SUD
– SARS-unique domain, UB2 – ubiquitin-like domain 2 preceding the papain-like
cysteine protease (PLpro), NAB – nucleic acid-binding domain, G2M – coronavirus
group 2 marker, TM1 and TM2 – transmembrane regions, ZF – zinc-ﬁnger, Y –
uncharacterized domain. As shown schematically in panel C, Δ indicates a deletion
of the X domain or of domains N, M, C, NM, or the complete SUD-coding sequences.
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orientation of the MluI-MluI fragment used as a negative control,
neither expressed Renilla luciferase nor was able to synthesize
viral RNA (Fig. 2, A and B, columns “NR”). These results clearly
indicate that Renilla luciferase activity is a good reporter for
analyzing viral genome replication.
To ﬁnd out the optimum time for the reporter-gene expression
by the engineered SARS-CoV replicon, the Renilla luciferase
activity was analyzed at different time-points after transfection
of pBAC-REP-RLuc into Vero E6 cells. As shown in Fig. 2C, the
reporter gene expression showed a linear increase between 18 and
53 h posttransfection (hpt), with the highest value of Renilla
luciferase activity detected around 53 hpt. Therefore, the expres-
sion between 24 and 48 hpt was recorded in our study.
The X macrodomain of SARS-CoV is dispensable for RTC activity
A few regions near the 50 end of the coronavirus genome (nsp1
of murine hepatitis virus, MHV (Denison et al., 2004; Brockway
and Denison, 2005, Tanaka et al., 2012), and nsp2 of MHV and
SARS-CoV (Graham et al., 2005)) have been shown to be dispen-
sable for virus replication (reviewed in Neuman et al., 2014). In
addition, the ADRP of Nsp3b, i.e. the X domain of human
coronavirus 229E (HCoV 229E) can be inactivated by mutation
without signiﬁcantly affecting viral replication in cell culture
(Putics et al., 2005). To ﬁnd out whether the X domain may
display another, as yet uncharacterized activity involved in viral
replication or transcription, we removed the coding sequence for
the complete domain from the SARS-CoV replicon and found that
the resulting replicon, pBAC-ΔX-REP-RLuc, was replication-
competent. Approximately 70–75% of the parental replicon
(pBAC-REP-RLuc) activity (Fig. 2E, column “REP”) was observed
for the expression of the X domain-deleted replicon (Fig. 2E,
column “ΔX”). To ensure that the reporter-gene expression
correlated with viral genome synthesis, Renilla luciferase activity
expressed by constructs lacking individual domains (in this case
the X domain) was directly compared with RNA synthesis. A high
level of viral RNA synthesis was observed for the X-domain-
deleted construct (Fig. 2F, column “ΔX”). Thus, not only is the
ADRP activity of the X domain not required for coronavirus
replication in tissue culture, as shown for HCoV 229E (Putics
et al., 2005), but the entire X domain is dispensable in case of
SARS-CoV (our data).
SUD is indispensable for SARS-CoV genome transcription/replication
In case of the SUD, we have shown that it preferentially binds
oligo(G) stretches (G-quadruplexes) (Tan et al., 2007, 2009). To
assess the importance of SUD for the activity of the RTC, the entire
SUD-encoding sequence was deleted from the SARS-CoV replicon,
as described above. The ability of the deleted construct pBAC-
ΔSUD-REP-RLuc to replicate its genome was compared to that of
the parental replicon pBAC-REP-RLuc. In contrast to the latter
(Fig. 2D, column “REP”), two independently prepared clones of
pBAC-ΔSUD-REP-RLuc, transfected in Vero E6 cells, expressed the
Renilla luciferase gene only at a level similar to background
activity, suggesting that the SUD is indispensable for SARS-CoV
RTC activity (Fig. 2D, cf. columns “ΔSUD“ with column “mock”).
Lack of trans-complementation of the replication-deﬁcient SUD-
lacking SARS-CoV replicon by the full-length SUD and SUD-NM
To answer the question whether the SUD function is required
exclusively in cis or can be provided in trans, the full-length
SUD or its more stable SUD-NM fragment was co-transfected
together with the SUD-deleted replicon pBAC-ΔSUD-REP-RLuc in
Huh-T7 cells susceptible to SARS-CoV (Gillim-Ross et al., 2004;
Fig. 2. Comparison of the level of Renilla luciferase expression (A) and viral RNA synthesis (B) by replication-competent (REP) and replication-deﬁcient (NR) SARS-CoV
replicons; time-course of RLuc expression by the SARS-CoV replicon (C); the effect of SUD deletion (two clones, clon1 and clon2) on Renilla luciferase expression (D), effect of
deletion of the X domain (ΔX), SUD macrodomains (ΔN and ΔM), and of the SUD-C subdomain (ΔC) on the expression of Renilla luciferase (E) and on viral RNA synthesis (F).
SARS-CoV replicons with deleted domains were transfected in Vero E6 cells and after 24 h of incubation, Renilla luciferase activity and the amount of viral RNA were
measured (see Materials and methods). Renilla luciferase activity and viral RNA synthesis were also measured after transfection of a replication-deﬁcient SARS-CoV replicon
(NR) and in mock-transfected cells (Cells). Data shown are from quadruplicate experiments, expressed as the mean value of RNA copies7standard deviation (SD). The
difference in expression of the full-length SARS-CoV replicon and its various mutants was found to be signiﬁcant, implying that values among them are greater than would
be expected by chance (0.014p40.001). Note that in the replication-deﬁcient SARS-CoV replicon (NR), the sequence of the MluI-MluI fragment is reversed, thus preventing
the formation of the replicase complex. RLU – relative light units.
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Hattermann et al., 2005). However, the reporter gene activity did
not exceed background level (Fig. 3, panel A). None of the
constructs expressing SUD or SUD-NM (columns 2 and 3, respec-
tively) was able to considerably enhance the extremely low
reporter gene activity of the SUD-lacking replicon co-transfected
with vector alone (column 1). Intriguingly, the co-expression of
SUD or SUD-NM with the replication-competent SARS-CoV repli-
con (REP-RLuc, columns 5 and 6, respectively) slightly inhibited
the Renilla luciferase activity expressed by the replicon co-
transfected with the vector pIVEX used as a control (column 4).
Assuming that the inability to complement the SUD-deleted
replicon by providing SUD or SUD-NM in trans was due to low
levels of protein production, we increased the amount of
expression using vaccinia virus (VV) MVA-T7 as a helper virus.
Previously, we have successfully used MVA-T7 to efﬁciently
express hepatitis A virus genes (Kusov et al., 2002). Indeed, the
transfection of constructs expressing SUD or SUD-NM followed by
infection with the helper virus MVA-T7 (a procedure known as
transinfection, Kusov et al., 2002) allowed immunological detec-
tion of SUD and SUD-NM using either polyclonal SARS-CoV anti-
Nsp3 (Rockland; result not shown) or monoclonal anti-His4 (Qia-
gen) (Fig. 3C). Note that the level of Renilla luciferase expression
by the SUD-deleted replicon was also increased, probably because
of more efﬁcient mRNA transcription from a cryptic promoter or
due to a helper effect of VV for replicon RNA synthesis, as we and
others have noticed previously (Sutter et al., 1995; Kusov et al.,
Fig. 3. Impact of SUD and SUD-NM proteins, provided in trans, on the activity of the full-length and SUD-deleted SARS-CoV replicons. Indicated DNAs were co-transfected in
Huh-T7 cells (A) or additionally infected with vaccinia virus MVA-T7 as a helper virus (see Materials and methods) (B). The infection and/or co-transfection mixtures were
replaced with growth medium and incubated for an additional 48 h. The cell lysates were analyzed for Renilla luciferase (A and B, po0.01) and anti-His immunological
activity in mixtures 2 and 3 shown in panel B (C). All experiments were run in triplicate and the average was employed for analysis. Error bars represent standard deviations
of the mean values. The difference in reporter protein activity of the full-length replicon and the SUD-lacking replicon was found to be statistically signiﬁcant (panel A,
p¼0.005; panel B, p¼0.01).
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2002). However, none of the proteins, SUD (Fig. 3B, column 2) or
SUD-NM (column 3), was able to increase the reporter-gene
expression of the SUD-deleted replicon pBAC-ΔSUD-REP-RLuc
(column 1), indicating that the function(s) of SUD cannot be
complemented in trans. To double-check these results, we have
tried to supplement the parental SARS-CoV replicon pBAC-REP-
RLuc. In line with the data presented in Fig. 3A, the co-expression
of SUD or SUD-NM rather partially inhibited the Renilla luciferase
activity of the replication-competent replicon (Fig. 3, cf. columns
4 and 5 in panels A and B), implying that possibly a ﬁne balance of
the proteins is crucial for the formation of the active SARS-CoV
replicase complex. Taken together, the functional activity of SUD in
cis could not be supplemented in trans, neither by the full-length
SUD nor by its more stable version SUD-NM consisting of the two
macrodomains, SUD-N and SUD-M.
The SUD-M macrodomain is crucial for the activity of the replication/
transcription complex
To assess the role of the subdomains of SUD for the activity of
the RTC, the SUD-N and SUD-M macrodomains and the C-terminal
subdomain (SUD-C) were deleted in separate experiments from
the sequence of the SARS-CoV replicon (Fig. 1). We compared the
activities of the replicons lacking individual SUD subdomains to
that of the parental SARS-CoV replicon, pBAC-REP-RLuc. The SARS-
CoV replicon lacking the SUD-N domain expressed 30 to 35% of the
Renilla luciferase activity of the parental replicon (Fig. 2E, column
“ΔN”). Accordingly, its RNA level was well detectable in contrast to
other SUD subdomain-deleted replicons (Fig. 2F, compare the
column “ΔN” with those for ΔM and ΔC). These data indicate
that the SUD-N macrodomain may also be considered dispensable
for SARS-CoV replication, similar to the X domain (see above),
although their effects on replication may be considered “minor” (X
domain) and “moderate” (SUD-N domain), respectively. In sharp
contrast, the Renilla luciferase activity expressed by the replicon
with the SUD-M domain deleted (Fig. 2E, column “ΔM”) did not
exceed the level of the activity expressed by the replication-
deﬁcient replicon pBAC-REP(NR)-RLuc (Fig. 2E, column “NR”). This
activity was similar to the background level detected in mock-
transfected cells (Fig. 2E, column “Cells”). The lack of replication of
the SUD-M domain-deleted replicon, deduced from the negligible
level of Renilla luciferase activity, was conﬁrmed by quantiﬁcation
of the viral genome (Fig. 2F, column “ΔM”). The pBAC-SUDΔC-
REP-RLuc replicon was able to replicate only to a signiﬁcantly
lower extent than the construct lacking the SUD-N domain (Fig. 2,
E and F, cf. columns “ΔC” and “ΔN”). Nevertheless, its Renilla
luciferase expression and the synthesis of viral RNAwere always at
detectable levels (Fig. 2, E and F, columns “ΔC”), in contrast to the
activity of the SUD-M-lacking replicon (column “ΔM”) or to that of
the replicon with the SUD-NM domains deleted (not shown). The
RTC activity of the latter replicons was either at background level
(columns “Cells”) or at the level of the replication-deﬁcient
construct (columns “NR”). In summary, among all tested SARS-
CoV replicons with the above-mentioned deletions, the replication
ability was mostly affected by the deletion of the SUD-M
macrodomain.
Charged amino-acid residues of the SUD-M macrodomain
presumably involved in G-quadruplex binding are essential for SARS-
CoV RTC function
Among all previously tested sets of amino-acid replacements
that were able to affect the binding of SUD to G-quadruplexes, the
mut4 set of mutations, comprising alanine substitutions of K565,
K568, and E571 of Nsp3, was most efﬁcient in preventing the
binding of oligo(G) (Tan et al., 2009). These amino-acid residues
are located in the loop connecting the second α-helix with the
third β-strand of the SUD-M domain, which was found to be
essential for replication of the SARS-CoV replicon (Fig. 2E and F). In
contrast, the mutations K476A and K477A (the mut2 set of
mutations) located in the dispensable SUD-N domain (Fig. 2E
and F) had only a minor effect on oligo(G)-binding in vitro (Tan
et al., 2009).
To compare the effect of mutations on viral genome replication/
transcription in vivo, the two sets of mutations (mut2 and mut4)
were introduced separately into two SARS-CoV replicons contain-
ing the full-length SUD sequence, pBAC-REP-RLuc and pBAC-ΔX-
REP-RLuc, which were able to efﬁciently replicate their genome as
judged by Renilla luciferase expression and viral RNA synthesis
(Fig. 2). A replicon lacking the SUD-C subdomain, pBAC-SUDΔC-
REP-RLuc, which contains both the SUD-N and SUD-M domains,
was not considered for site-directed mutagenesis because of its
low activity.
The impact of the mut2 and the mut4 set of mutations on the
activity of the RTC was examined by reporter gene expression and
viral RNA synthesis as mentioned above. Compared to the original
constructs, the non-mutated replicon pBAC-REP-RLuc (Fig. 4A) and
its X domain-deleted derivative pBAC-ΔX-REP-RLuc (Fig. 4B), the
corresponding replicons containing the mut2 set of mutations
(K476A and K477A) expressed Renilla luciferase activity three
times more weakly (Fig. 4A, -SUDmut2-), or even at the same
level (Fig. 4B, -ΔX-SUDmut2-). Probably, this difference is con-
nected with the reduced activity of the SARS-CoV replicon lacking
the X domain (see Fig. 2E and F). In contrast to the effect of mut2
variants, the Renilla luciferase activity of replicons containing the
mut4 set of mutations was negligible, thereby emphasizing the
crucial role of the residues altered in the mut4 set of mutations for
genome replication (Fig. 4A and B, -SUDmut4- and -ΔX-SUDmut4-
). These results were in close agreement with the levels of
quantiﬁed viral RNA (not shown). Taken together, the effect of
charged amino-acid residues on the in-vitro binding of SUD-NM to
G-quadruplexes strictly correlated with the activity of the mutated
SARS-CoV replicons in vivo.
Discussion
The highly infectious and virulent Severe Acute Respiratory
Syndrome coronavirus (SARS-CoV), classiﬁed as a biosafety level-3
agent (BSL3), can only be handled in specially equipped labora-
tories. To overcome this limitation and to avoid the use of
dangerous live virus, SARS-CoV replicons have been engineered
(Almazán et al. 2006, 2014; Ge et al., 2007; Eriksson et al., 2008;
Pan et al., 2008; Wang et al., 2008). Here, we have constructed a
SARS-CoV replicon containing Renilla luciferase as reporter gene,
thus allowing not only the easy screening of chemical libraries for
antivirals interfering with replication of viral RNA and the char-
acterization of antiviral lead compounds, but also studies of the
function of various viral proteins and regulatory sequence ele-
ments by reverse genetics.
Our aim was to elucidate the functional role of the three
sequential macrodomains within Nsp3 for the activity of the
SARS-CoV RTC. To this end, we have created various SARS-CoV
replicons with deleted and/or mutated macrodomains. First, the X
domain-encoding sequence was deleted from the Renilla
luciferase-containing SARS-CoV replicon and the resulting replicon
was tested for its ability to express the reporter gene. The X
domain has been shown to exhibit a weak ADRP activity in most
coronaviruses examined, but we have previously shown that this
activity is not completely conserved across the family; thus, the X
domain of the Beaudette strain of Infectious Bronchitis Virus (IBV)
is unable to bind ADP-ribose due to replacement of a Gly-Gly-Gly
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triplet in the binding site by Gly-Ser-Gly (Piotrowski et al., 2009).
Furthermore, Putics et al. (2005) reported that the ADRP activity of
HCoV 229E is not essential for genome replication of this virus in
cell culture. In this study, we ﬁnd that the replicon pBAC-ΔX-REP-
RLuc expressed a high level of Renilla luciferase and was able to
synthesize viral RNA after transfection into mammalian cells (Vero
E6 or Huh-T7, a derivative of SARS-CoV-susceptible Huh-7 cells
(Gillim-Ross et al., 2004; Hattermann et al., 2005)). This indicates
that the X domain does apparently not carry another, as yet
unidentiﬁed, activity that would be essential for SARS-CoV repli-
cation/transcription. In sharp contrast to results with the deleted X
domain, the SUD-lacking replicon, pBAC-ΔSUD-REP-RLuc, abro-
gated reporter gene expression and the synthesis of viral RNA
(Fig. 2D and not shown, respectively). To our knowledge, this is the
ﬁrst description of the indispensability of SUD for SARS-CoV
genome replication. The most plausible explanation for this
observation is an essential role of the SUD-M macrodomain for
viral RNA synthesis (see below).
Interestingly, all our attempts to complement in trans the SUD
function by co-expression of the full-length SUD or SUD-NM
failed, albeit the expression was evidenced by immunological
detection of the proteins (see Fig. 3). Also, the replication of the
complete SARS-CoV replicon was not enhanced when a full-length
SUD or SUD-NM were provided in trans (Fig. 3). The inability to
supply SUD activity in trans rules out a hypothetical enzymatic
activity of SUD. Taken together, these results indicate that the
functionally active SUD is required only in cis or, alternatively, a
ﬁne balance of the proteins is essential for the formation of the
active SARS-CoV replicase complex. These observations may sub-
stantiate the previously published data on enhancement of SARS-
CoV reporter activity by the co-expression of Nsp3.1, which
comprises domains X and SUD (Pan et al., 2008). Now we can
assume that this enhancement was mainly due to the presence of
the X domain within Nsp3.1. Alternatively, the three sequentially
positioned macrodomains, i.e. X, SUD-N, and SUD-M, may have
(an) as yet unidentiﬁed function(s) enhancing SARS-CoV genome
replication. Since full-length SUD was found to be crucial for SARS-
CoV genome replication (Fig. 2D) and not able to complement in
trans (Fig. 3), we decided to gain further insight into the role of
each SUD macrodomain for RTC activity. In addition, the C-
terminal SUD subdomain (SUD-C) was also investigated by
removal of the SUD-C-coding sequence from the SARS-CoV repli-
con. The deletion of the SUD-M domain completely abolished both
replicon activities, thus indicating that the SUD-M domain is
indispensable for SARS-CoV genome replication. In contrast, the
SUD-N domain was revealed to be non-essential for RTC activity
since its removal abolished neither Renilla luciferase expression
nor viral RNA synthesis (Fig. 2, E and F, columns “ΔN”). The same
is true for the SUD-C subdomain, although the RTC activity of the
SUD-C-lacking replicon was always at a low level (Fig. 2, E and F,
columns “ΔC”). Intriguingly, three amino-acid residues (K565,
K568, and E571) located in the loop following the second α-
helix of SUD-M and responsible for the interaction of SUD with
oligo(G)-nucleotides have previously been identiﬁed (Tan et al.,
2009). We propose that the SUD-oligo(G) interaction is required
for SARS-CoV genome replication. The SARS-CoV genome contains
a number of conserved G4 stretches (Johnson et al., 2010) that
could be binding-partners for SUD. Oligo(G) sequences are capable
of forming G-quadruplexes, even if they comprise a few non-
guanines; thus, the NMR structure of the prototype G-quadruplex
that we used for docking into the SUD-NM cavity contains 8 non-
guanines among 23 nucleotides (Dai et al., 2006). Therefore, oligo
(G) regions such as, e.g., 50-GGGAGGUAGG-30, which is found
conserved in the Nsp2- and Nsp12-coding regions in the genomes
of different SARS-CoV strains (Johnson et al., 2010), are candidates
for interaction with SUD.
While these observations support an essential role of the SUD-
M domain in replication/transcription of the SARS-CoV genome,
Fig. 4. Effect of amino-acid replacements in the SUD macrodomains on viral genome transcription/replication. Indicated mutations in SUD-N and SUD-M (designated –
SUDmut2- and -SUDmut4-, respectively) were introduced into the SARS-CoV replicon pBAC-REP-RLuc (A) and its derivative lacking the X domain, pBAC-ΔX-REP-RLuc (B)
(see diagrams at the right side of the constructs). The ability of the constructs to exhibit Renilla luciferase activity is presented as mean values of triplicate experiments7SD
(po0.05). A putative model of G-quadruplex binding to SUD-NM, obtained by automated docking into the crystal structure (C, modiﬁed from Tan et al., 2009). The SUD-N
and SUD-M macrodomains are in violet and cyan, respectively. The G-quadruplex as found in the BCL2 promoter region (PDB code: 2F8U, Dai et al., 2006) is in orange. The
mut2 set of mutations (K476AþK477A), located at the C-terminus of the SUD-N domain, is indicated by yellow sticks. The mut4 set of mutations (K565AþK568AþE571A), of
SUD-M, is indicated by green sticks. These residues belong to a cluster of charged amino-acid residues located in the second α-helix of SUD-M and in the loop connecting it
with the third β-strand (R562, K563, K565, K568, and E571, green, red, blue, magenta, and orange label, respectively) (D).
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probably via interaction with G-rich stretches forming G-quad-
ruplexes, we have to consider a potential negative effect of SUD
domain deletions on the activity of the papain-like protease
(PLpro), located immediately downstream of SUD. Such a modula-
tion of PLpro activity by ﬂanking regions has been reported for
SARS-CoV PLpro (Harcourt et al., 2004; Han et al., 2005) and
alphacoronavirus PL2pro (Ziebuhr et al., 2001, 2007). Therefore,
to demonstrate a direct correlation between the G-quadruplex
interaction and the replication ability of SARS-CoV replicons and to
exclude a possible modulating effect of domains preceding the
PLpro, we reasoned to leave the SUD intact but mutate the amino-
acid residues putatively involved in SUD-binding to G-
quadruplexes. The replacement of charged amino-acid residues
by alanine (K565A, K568A, and E571A, mut4 set of mutations) on
the surface of the SUD-M domain that is oriented towards the
SUD-N domain and remote from the PLpro (Tan et al., 2009),
completely abrogated the Renilla luciferase expression (Fig. 4)
and the synthesis of viral RNA (not shown), both in the context of
the SARS-CoV replicon and its X-lacking version. In contrast, and
consistent with the previously described marginal effect of the
lysine residues at positions 476 and 477 of the SUD-N domain on
G-quadruplex-binding in vitro (Tan et al., 2009), the introduction
of the mut2 set of mutations (K476A and K477A) into the above-
mentioned replicons had only a minor effect on expression of
Renilla luciferase (Fig. 4) and viral RNA synthesis (not shown). In
agreement with this, the replicon with the SUD-N domain deleted
was able to replicate (Fig. 3E and F, columns “ΔN”).
These results were consistent with our hypothesis that SARS-
CoV genome replication requires the interaction of SUD with oligo
(G)-containing nucleic acids (Tan et al., 2007, 2009). Amino-acid
replacements (mut4), which in in-vitro experiments abrogated the
interaction of mutated SUD-NM with oligo(G) (Tan et al., 2009),
resulted in a replication-defective construct. In contrast, the mut2
set of mutations with negligible effect on oligo(G)-binding to SUD-
NM in vitro (Tan et al., 2009) resulted in a viable replicon.
Taken together, these data suggest SUD amino-acid residues
that are strictly required for SARS-CoV genome replication. These
residues (lysine residues 565, 568, and glutamate 571) are located
in the loop connecting the second α-helix with the third β-strand
of the SUD-M macrodomain; interestingly, the two lysine residues
belong to a region shown to be involved in G10-binding by NMR-
shift perturbation analysis (Johnson et al., 2010) and are involved
in interactions with a G-quadruplex according to our docking
model (Fig. 4C and D). Considering their electrostatic potential, the
replacement of these amino-acid residues by alanine will affect the
charge distribution within the binding site for G-quadruplexes or
other nucleic acids (Supplementary Fig. 2 and Supplementary text
B). Such a modiﬁcation of the binding site's electrostatic potential
results in abrogation of the SUD – nucleic-acid interaction (Tan
et al., 2009) that is required for SARS-CoV genome replication in a
cell-based assay (Supplementary Fig. 2). On the other hand, the
replacement of lysine by alanine at positions 476 and 477 did not
signiﬁcantly affect either the electrostatic potential of the binding
site (Supplementary Fig. 2) or the direct interaction with the
G-quadruplex (Fig. 4C). Although we did not construct the replicon
containing arginine to alanine replacement at position 562, we
speculate that this highly conserved arginine residue is also
involved in G-quadruplex binding, since it is located in close
proximity to the binding cavity (Supplementary Fig. 3 and
Fig. 4D; R562, green label) and has also been identiﬁed as part
of the nucleic-acid binding site in the NMR-shift perturbation
experiments reported by Johnson et al. (2010). In contrast, the
lysine residue at position 563 seems to be oriented away from the
binding pocket (Fig. 4D; K563, red label), thereby preventing its
participation in oligo(G) interaction. The participation of the
strictly conserved E571, which is located close to the binding site
but negatively charged (Fig. 4D, orange label, and Supplementary
Fig. 3) needs to be further investigated. In summary, we have
identiﬁed amino-acid residues essential for SARS-CoV genome
replication, which requires SUD-oligo(G) interaction. Interestingly,
this cluster of charged amino-acid residues located in the second
α-helix of the SUD-M domain, or in the loop following it (Fig. 4D;
R562, K565, K568, and E571, green, blue, magenta, and orange
labels, respectively), is conserved among established human SARS-
CoV strains (Urbani, Frankfurt, Tor2, GZ02, and BJ01) and SARS-
CoV-related bat and civet isolates (RsSHC014, RS3367, Rs672/2006,
HKU3-1, Rf1, Rm1, Rp3, SZ3, SZ16, Bat273, Bat 279, and BM48)
(Supplementary Fig. 3).
Despite strong evidence for SUD-M domain - G-quadruplex
interaction demonstrated in vitro (Tan et al., 2007, 2009) as well as
in vivo (this work), we do not rule out a role in replication of other
possible SUD functions, such as the SUD-SUD, SUD-UB1, and SUD-
X domain-domain interactions described previously (Neuman et
al., 2008). Nevertheless, supporting a crucial role for oligo(G)-
binding in viral genome replication, a similar, but not identical,
stretch of charged amino-acid residues was also found to be
conserved in the genome of the newly emerging human Middle-
East Respiratory Syndrome coronavirus (MERS-CoV) and in the
genomes of the closely related bat CoVs, HKU4 and HKU5, as well
as in the genome of CoVs isolated from dromedars, which are
supposed to be a primary animal reservoir of MERS-CoV (Memish
et al., 2014) (see Supplementary Fig. 3). Intriguingly, as seen for the
SUD-M macrodomain, we found the putative M domain of MERS-
CoV to bind exclusively oligo(G) (and not oligo(A), oligo(C), or oligo
(U)) nucleotides (Lei et al., personal communication). It is highly
probable that this property is attributable to the stretch of
conserved charged residues on the surface of the M domain of
MERS-CoV (see Supplementary Fig. 3). Further studies will be
required to elucidate the impact of the deletions and mutations
described here at the level of the full-length SARS-CoV genome
and, in particular, to answer the question whether any second-site
mutation(s) can rescue the mutated virus.
Conclusion
In this contribution, we demonstrate, for the ﬁrst time, the
functional role of the SUD subdomains within the replication–
transcription activity of the Severe Acute Respiratory Syndrome
Coronavirus (SARS-CoV). Contrary to the dispensable SUD-C and
SUD-N subdomains as well as to the X domain preceding SUD in
the genome, the SUD-M macrodomain was found to be crucial for
the activity. The indispensability of this subdomain might be
connected with its ability to bind oligo(G) stretches/G-quadru-
plexes as concluded from the results of site-directed mutagenesis
of charged amino-acid residues in the loop connecting the second
α-helix of SUD-M with the third β-strand. Intriguingly, a similar,
but not identical, cluster of residues is observed in the genomes of
the newly emerging human Middle-East Respiratory Syndrome
coronavirus (MERS-CoV), MERS-related dromedary camel CoV,
and bat CoVs HKU4 and HKU5.
Materials and methods
Cells and viruses
African green monkey kidney cells (Vero E6) and Huh-T7 cells,
a derivative of human hepatocellular carcinoma Huh-7 cells
(Nakabayashi et al., 1984) that constitutively expresses the T7
RNA polymerase (Shultz et al., 1996), were grown in Dulbecco's
modiﬁed minimal essential medium (DMEM) supplemented with
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2 mM glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin
sulfate, and fetal calf serum (10% v/v). Huh-T7 cells were addi-
tionally supplemented with geneticin (G-418 sulfate, 400 mg/ml).
The recombinant, non-cytopathic vaccinia virus (VV) MVA-T7 was
used to produce SUD or its subdomains NþM (SUD-NM) in order
to complement in trans the activity of the SARS-CoV replicon
lacking SUD. MVA-T7 was propagated in BHK-21 baby hamster
kidney cells and titrated as described previously (Kusov et al.,
2002). Other cell and culture conditions have been described in
Almazán et al. (2006) and Kusov et al. (2006).
Construction of the SARS-CoV replicon containing reporter gene
To generate a SARS-CoV replicon containing a reporter gene, we
have taken advantage of the strategy previously described for the
construction of a SARS-CoV replicon lacking a reporter gene
(Almazán et al., 2006). A Renilla luciferase as a reporter gene
(RLuc, Renilla reniformis, also known as sea pansy) was PCR-
ampliﬁed using pRL-SV40 DNA as a template (Promega; acc.
AF025645), forward and reverse primers (Supplementary
Table 1), and proof-reading DNA polymerase (AkkuPrime Pfx
SuperMix, Invitrogen). The transcription regulatory sequence for
the SARS-CoV M protein (TRS M) and a Kozak sequence enhancing
expression in eukaryotic cells were included in the forward RLuc
primer (Almazán et al., 2004; Kozak, 1989). The PCR amplicon was
treated with AscI and BamHI and introduced between the same
restriction sites of the SARS-CoV replicon pBAC-REP-URB (Almazán
et al., 2006) producing the reporter gene (RLuc)-containing SARS-
CoV replicon, referred to as pBAC-REP-RLuc (Supplementary
Fig. 1). To exactly conform to the Kozak sequence, the second
amino-acid residue of Rluc (tyrosine) was replaced by alanine. This
replacement was successfully employed in the RLuc expression
vector pBS-35S-Rluc-Ala (acc. number AY189983).
Introduction of deletions and point mutations into the Renilla gene-
containing SARS-CoV replicon
All desired deletions and point mutations were introduced into
the pBAC-REP-RLuc plasmid encoding polyproteins pp1a and
pp1ab as replicase and RLuc as reporter protein (see above).
However, to simplify the cloning procedure, we used as template
for site-directed mutagenesis the shorter plasmid pBAC-SfoI-MluI
encoding only the N-terminal half of polyprotein 1a (Nsp1–Nsp3)
of SARS-CoV (Almazán et al., 2006). In brief, a Phusion Hot Start
DNA polymerase (Phusion Site-Directed Mutagenesis Kit, Finn-
zymes), which ensures high ﬁdelity for the ampliﬁcation of large
plasmids, was employed to extend perfectly matched 50-phos-
phorylated forward and reverse primers (Supplementary Table 1)
that border the deleted area as schematically exempliﬁed in
Supplementary Fig. 1B for deletion of the complete SUD sequence.
The ampliﬁcation mixture was treated with DpnI to destroy the
original template DNA and the amplicon was circularized with
Quick T4 DNA ligase (Finnzymes). An aliquot of the ligation
mixture was transformed by electroporation (2.5 kV, 200 Ω,
25 mF) into electrocompetent E. coli cells (DH10B, NEB 10-beta,
New England Biolabs) or HST02 (Takara) that are suitable for
transformation of long-size plasmids. Positive clones were
initially identiﬁed by restriction analysis and then conﬁrmed by
sequencing. An agarose gel-puriﬁed SfoI-ΔSUD-MluI fragment
was transferred into dephosphorylated pBAC-REP-RLuc
(Supplementary Fig. 1A) that was restricted with SfoI and MluI.
For this procedure, the DNA ligase 〈long〉 optimized for cloning
large DNA fragments was used as recommended by the manufac-
turer (Takara). The efﬁciency of transformation was tremendously
increased after removing components of the ligation buffer by
sodium acetate/ethanol precipitation. The resulting SUD-lacking
plasmid (ΔSUD), which encoded the Renilla luciferase reporter
gene, was still replication-deﬁcient because of the absence of the
MluI-MluI fragment. To restore all replicase components, this
fragment was re-introduced at the MluI recognition site according
to the procedure for cloning long DNA fragments (see above). The
correct orientation of the MluI-MluI fragment was proven by StuI
digestion prior to sequencing. The plasmid with reverse orienta-
tion of the MluI-MluI fragment was used as negative, non-
replicating (NR) control.
A similar cloning strategy was employed to introduce point
mutations into the replicon pBAC-ΔX-REP-RLuc lacking the X
domain and into the full-length replicon pBAC-REP-RLuc. Two sets
of mutations – K476A and K477A (mut2) in the SUD-N domain and
K565A, K568A, and E571A (mut4) in the SUD-M domain – were
introduced into both replicons. Phosphorylated asymmetric for-
ward and reverse primers overlapping only within a short
sequence (Supplementary Table 1) were employed for site-
directed mutagenesis as described above. Mut2- and mut4-
containing clones were identiﬁed by BtsI and BstAPI digestion,
respectively. The ORF of all constructed SARS-CoV replicons bear-
ing deletions or mutations within Nsp3, schematically depicted in
Fig. 1C (ΔSUD, ΔX, SUD-ΔN, SUD-ΔM, SUD-ΔNM, and SUD-ΔC
replicons) and Fig. 4 (-SUDmut2- and -SUDmut4-, -ΔX-SUDmut2-
and -ΔX-SUDmut4-), was veriﬁed by complete sequencing of SfoI-
MluI fragments (LGC Genomics). Details of the cloning procedures,
restriction analysis of constructed plasmids, their maps and
sequences can be provided upon request.
Transfection of SARS-CoV replicons in Vero E6 or Huh-T7 cells
Grown in twelve-well plates to 95% conﬂuence, Vero E6 or
Huh-T7 cells (1105 cells/well) were transfected with deleted or
mutated SARS-CoV replicons by using Lipofectamin 2000 accord-
ing to the manufacturer's speciﬁcations (Invitrogen). At indicated
time-points (see ﬁgure legends), the cells were lysed and the
Renilla luciferase activity and/or viral RNA genome was measured
in cell lysates (see below). All experiments were performed in
triplicate or quadruplicate and the mean values and standard
deviations (SD) are presented. Plasmid pRL-SV40 DNAs (Promega,
acc. AF025645) and the wild-type SARS-CoV replicon were applied
as control reporters in all transfection experiments.
Assay of Renilla luciferase activity
To lyse the cells, 150 ml/well of Passive lysis buffer (Promega)
was added to the washed cell monolayer in 12-well plates (1 ml/
well, phosphate-buffered saline, PBS) and incubated for 20 min at
room temperature (RT) with rigorous shaking. The cells were
further lysed by a freeze (80 1C) / thaw procedure, vortexed,
and centrifuged (18,400 g, 1 min). To a 20-ml aliquot of clear
supernatant, a mixture of Renilla luciferase assay and enhancer
solutions (50 ml each, Biotium) was added and the luminescence
was immediately measured using an Anthos Lucy-3 luminescence
plate reader (Anthos Labtec Instruments). Data presented in
Figs. 2, 3, and 4 are from quadruplicate experiments and are
expressed as the mean value7standard deviation (SD). The
differences in Renilla luciferase expression of the full-length
SARS-CoV replicon and its various mutants were analyzed with
Sysstat (SigmaPlot Software Inc.) and found to be statistically
signiﬁcant implying that values are greater than would be
expected by chance.
Viral RNA quantiﬁcation
To isolate the viral RNA from Vero E6 cells transfected with
SARS-CoV replicons containing deletions or mutations, the cells
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were trypsinized as usual and spun down (1000 g, RT, 5 min).
The cell pellet was washed with PBS and cells were suspended in
100 ml PBS before dividing into two aliquots. A 20-ml aliquot of cell
suspension was used for the evaluation of Renilla luciferase
activity after lysis of pelleted cells in 50 ml Passive lysis buffer as
described (see above). The total RNA was isolated from 80 ml of cell
suspension using the RNeasy extraction kit and DNaseI treatment
as recommended by the supplier (Qiagen). Trace amounts of DNA
were removed from RNA preparations (20 ml) by additional treat-
ment (37 1C, 30 min) with 1 unit of RNase-free DNase I in DNase
buffer containing MgCl2. The DNase was inactivated by adding 1 ml
of 25 mM EDTA solution and heating at 65 1C for 10 min. The yield
of total RNA was quantiﬁed by using a NanoDrop 1000 UV/Vis
spectrophotometer (Thermo Fisher). An equal amount (500 ng) of
RNA samples extracted from cells transfected with deleted SARS-
CoV replicons was directly used as template for the ﬁrst-strand
cDNA synthesis. The reaction mixture (25 ml) additionally contain-
ing a reverse ΔX primer (200 nM, see Supplementary Table 1) and
all four standard dNTPs (800 mM each) was pre-incubated at 65 1C
for 5 min, chilled on ice to destroy any secondary structure of viral
RNA and, after addition of RNase inhibitor (1 ml, Ribolock, Thermo
Scientiﬁc) and reverse transcriptase (40 units, Thermo Scientiﬁc),
further incubated at 45 1C for 60 min. The reverse transcriptase
was inactivated by incubation at 70 1C for 5 min. A similar mixture
without reverse transcriptase was used as a control. A 5-ml aliquot
of the mixture was used for Real-Time PCR after addition of
forward and reverse primers (0.3 mM each, see Supplementary
Table 1; note that these primers represent a sequence of Nsp1
allowing to determine genome replication, but not transcription),
a ﬂuorescence-quenching primer (6FAM-ACCATCAAGTATGGTGA-
CAGCTGCTCT-BBQ, 0.2 mM; TIB MolBiol), and a Maxima Probe
qPCR Master Mix (Fermentas, MBI) in a total volume of 20 ml. A
calibration curve was prepared by log10 dilution of pBAC-REP-RLuc
in nuclease-free water. The measurements were performed in
triplicate or quadruplicate; mean values of genome copies and
SD are presented. Data shown are from quadruplicate experi-
ments, expressed as the mean value of RNA copies7standard
deviation (SD). The statistical analysis of RNA copies for the full-
length SARS-CoV replicon and mutants was performed as
described above.
Generation of plasmids to express full-length SUD and SUD-NM in
mammalian cells
To express in Huh-T7 cells the full-length SUD and its more
stable derivative SUD-NM comprising the two macrodomains
(SUD-N and SUD-M) (Tan et al., 2007), their coding sequence
was placed under control of the T7 promoter in the context of the
pIVEX WG vector (Roche). A complete SUD sequence was obtained
from pET-Blue2-SUD (Tan et al., 2007) by digestion with NcoI and
XhoI restriction enzymes. Then, the puriﬁed insert was cloned into
NcoI-XhoI-treated and dephosphorylated vectors resulting in
plasmids named pIVEX-SUD. A SUD-NM sequence was PCR-
ampliﬁed using the proof-reading Pfu DNA polymerase, the
template pQE30-Xa-SUD-NM, and the forward and reverse pri-
mers (Supplementary Table 1). The puriﬁed amplicon was treated
with NcoI and SmaI and inserted into the dephosphorylated vector
pIVEX WG digested with the same enzymes, resulting in plasmid
pIVEX-SUD-NM.
Complementation in trans of SUD and SUD-NM and their
immunological detection
Huh-T7 cells (1105 cells/well) cotransfected with 0.25 mg
SUD-lacking or parental SARS-CoV replicon and 1 mg pIVEX-SUD
or pIVEX-SUD-NM plasmids were infected with helper vaccinia
virus MVA-T7 (multiplicity of infection, moi, around 5 as pre-
viously described (Sutter et al. 1995; Kusov et al., 2002)). After one
hour, the infection mixture was replaced with growth medium
and incubation was continued for 48 h. To measure Renilla
luciferase activity, the cells were lysed using Passive Lysis Buffer
(Promega) as described above. Complementation experiments
were run in triplicate and the mean values were employed for
analysis. To detect viral proteins, aliquots of cell lysates were
boiled with 1% sodium dodecyl sulfate (SDS) and proteins were
separated by 12% denaturing polyacrylamide gel (SDS-PAGE)
before transfer to PVDF membranes (Immobilon-P, Millipore).
His-tagged proteins (full-length SUD or SUD-NM) were immuno-
logically detected using either polyclonal SARS-CoV anti-Nsp3
(dilution 1:1000; Rockland, not shown) or monoclonal anti-His4
(1:5000, Qiagen) as primary antibody. Alkaline phosphatase (AP)-
conjugated anti-rabbit or anti-mouse IgG was used as a secondary
antibody (1:10000, Sigma).
Docking of a G-quadruplex to SUD-NM
Atomic coordinates for a typical G-quadruplex were obtained
from the Protein Data Bank (PDB; PDB code 2F8U, Dai et al., 2006).
The G-quadruplex was docked into the SUD-NM structure deter-
mined previously (Tan et al., 2009) using the program AUTODOCK
(Morris et al., 2009).
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